AR008858A1 - Preparados farmaceuticos que contienen derivados 1-hidroxi-2-(1h) piridona, procedimiento para su obtencion y empleo de los mismos para la preparacion deun medicamento para el tratamiento y profilaxis de micosis cutaneas. - Google Patents

Preparados farmaceuticos que contienen derivados 1-hidroxi-2-(1h) piridona, procedimiento para su obtencion y empleo de los mismos para la preparacion deun medicamento para el tratamiento y profilaxis de micosis cutaneas.

Info

Publication number
AR008858A1
AR008858A1 ARP970104430A ARP970104430A AR008858A1 AR 008858 A1 AR008858 A1 AR 008858A1 AR P970104430 A ARP970104430 A AR P970104430A AR P970104430 A ARP970104430 A AR P970104430A AR 008858 A1 AR008858 A1 AR 008858A1
Authority
AR
Argentina
Prior art keywords
treatment
same
prophylaxis
hydroxy
procedure
Prior art date
Application number
ARP970104430A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7807116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR008858(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR008858A1 publication Critical patent/AR008858A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Un preparado farmacéutico que contiene un formador de gel hidrofilo, agua y un derivado 1-hidroxi-2-(1H) piridona de la formula I, o una salfisiologicamente compatible del compuesto de la formula I, significando R1, R2 y R3, que son iguales odife rentes, un átomo de hidrogeno o alquilo con 1 a 4átomos de carbono, y significando R4 un radical hidrocarbonado saturado con 6 a 9 átomos, un procedimiento para su obtencion y el empleo de los mismos parapreparar un medicamento util para eltratamien to y la profilaxis de micosis cutáneas.
ARP970104430A 1996-09-27 1997-09-25 Preparados farmaceuticos que contienen derivados 1-hidroxi-2-(1h) piridona, procedimiento para su obtencion y empleo de los mismos para la preparacion deun medicamento para el tratamiento y profilaxis de micosis cutaneas. AR008858A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19639816A DE19639816A1 (de) 1996-09-27 1996-09-27 Antimykotische Mittel mit hoher Wirkstofffreisetzung

Publications (1)

Publication Number Publication Date
AR008858A1 true AR008858A1 (es) 2000-02-23

Family

ID=7807116

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104430A AR008858A1 (es) 1996-09-27 1997-09-25 Preparados farmaceuticos que contienen derivados 1-hidroxi-2-(1h) piridona, procedimiento para su obtencion y empleo de los mismos para la preparacion deun medicamento para el tratamiento y profilaxis de micosis cutaneas.

Country Status (35)

Country Link
US (3) US7018656B2 (es)
EP (1) EP0928192B1 (es)
JP (1) JP2001501609A (es)
KR (1) KR100457850B1 (es)
CN (1) CN1149992C (es)
AR (1) AR008858A1 (es)
AT (1) ATE216882T1 (es)
AU (1) AU718837B2 (es)
BG (1) BG63864B1 (es)
BR (1) BR9711559A (es)
CA (1) CA2267160C (es)
CY (1) CY2371B1 (es)
CZ (1) CZ291170B6 (es)
DE (2) DE19639816A1 (es)
DK (1) DK0928192T3 (es)
ES (1) ES2176702T3 (es)
HK (1) HK1022268A1 (es)
HU (1) HU228297B1 (es)
ID (1) ID22149A (es)
IL (1) IL129140A (es)
MA (1) MA24331A1 (es)
MY (1) MY117863A (es)
NO (1) NO321899B1 (es)
NZ (1) NZ334849A (es)
OA (1) OA11026A (es)
PL (1) PL188840B1 (es)
PT (1) PT928192E (es)
RS (1) RS49596B (es)
RU (1) RU2181281C2 (es)
SI (1) SI0928192T1 (es)
TR (1) TR199900723T2 (es)
TW (1) TW558442B (es)
UA (1) UA52699C2 (es)
WO (1) WO1998013042A1 (es)
ZA (1) ZA978638B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040039030A1 (en) * 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
JPWO2003105903A1 (ja) * 2002-06-18 2005-10-13 ポーラ化成工業株式会社 抗真菌医薬組成物
CN100425233C (zh) * 2005-01-12 2008-10-15 复旦大学 一种鼻腔用尼莫地平凝胶剂
US20080176908A1 (en) * 2007-01-18 2008-07-24 Mcanally Weylan R Method of using squalene monooxygenase inhibitors to treat acne
MX2007009796A (es) * 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
WO2010069519A1 (en) 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Topical compositions comprising at least one active ingredient poorly soluble in water and biopolymers such as hyaluronic acid with a pka-value between 5-7
WO2012009794A1 (en) * 2010-07-19 2012-01-26 Brusells Ventures Corp. Antimicrobial medical gel composition comprising etherified hydroxyethylcellulose
CN105797696A (zh) * 2016-03-23 2016-07-27 广东省工程技术研究所 一种分子印迹整体柱的制备方法
KR102166485B1 (ko) * 2018-04-12 2020-10-15 숙명여자대학교산학협력단 식품 신선도 유지를 위한 항균성 하이드로겔

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968118A (en) 1968-08-31 1976-07-06 Hoechst Aktiengesellschaft Process for the manufacture of 1-hydroxy-2-pyridones
NL156397B (nl) * 1968-08-31 1978-04-17 Hoechst Ag Werkwijze voor het bereiden van preparaten tegen schimmelaandoeningen, gevormde preparaten, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen.
US4185106A (en) 1972-07-11 1980-01-22 Hoechst Aktiengesellschaft Pyridones as antidandruff agents
DE3140954A1 (de) 1981-10-15 1983-05-05 Hoechst Ag "verwendung von 1-hydroxy-2-pyridonen zur prophylaxe und behandlung von akne"
GB8302683D0 (en) 1983-02-01 1983-03-02 Unilever Plc Skin treatment composition
JPS6169721A (ja) 1984-09-13 1986-04-10 Kao Corp 抗真菌組成物
GB8524508D0 (en) * 1985-10-04 1985-11-06 Beecham Group Plc Composition
WO1987002580A1 (en) 1985-11-04 1987-05-07 Dermatological Products Of Texas Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
EP0241918B1 (de) 1986-04-18 1992-05-27 Hoechst Aktiengesellschaft 1-Hydroxy-2-pyridone, Verfahren zu ihrer Herstellung und Arzneimittel, die sie enthalten, sowie bei der Herstellung der 1-Hydroxy-2-pyridone gebildete Zwischenprodukte
NL8601762A (nl) 1986-07-07 1988-02-01 Bouke Jan Lange Werkwijze voor de reiniging en conditionering en eventuele medicinale behandeling van het haar en de hoofdhuid, een voor dit doel bruikbare tweefasen shampoo, alsmede een verpakking daarvoor.
JPS63230640A (ja) * 1987-03-19 1988-09-27 Shiseido Co Ltd 経皮吸収促進剤及びこれを含有する皮膚外用製剤
US5641475A (en) 1987-05-15 1997-06-24 Tristrata, Inc. Antiodor, antimicrobial and preservative compositions and methods of using same
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
LU86944A1 (fr) 1987-07-17 1989-03-08 Oreal Composition a base de derives d'hydroxypyridone pour diminuer la chute des cheveux
LU86945A1 (fr) * 1987-07-17 1989-03-08 Oreal Compositions pharmaceutiques et cosmetiques a base de pyridones et d'agents antibacteriens
JPS6468327A (en) * 1987-09-08 1989-03-14 Teisan Seiyaku Kk Warming type insulin-containing plaster
DE3856302T2 (de) * 1987-10-22 1999-09-09 Procter & Gamble Chelatbildner enthaltende Lichtschutzmittel
US5071639A (en) * 1988-03-22 1991-12-10 Shiseido Company Ltd. Nail cosmetic composition
HU202098B (en) 1988-08-05 1991-02-28 Istvan Laczko Nail polish remover without aceton
DE3826914A1 (de) * 1988-08-09 1990-02-15 Henkel Kgaa Farbstabilisierung von antimikrobiellen zubereitungen
US5116603A (en) 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
JPH03120230A (ja) * 1989-10-04 1991-05-22 Nippon Mining Co Ltd 薬効成分の経皮吸収促進剤及び経皮吸収型製剤
JPH0623087B2 (ja) 1989-10-09 1994-03-30 花王株式会社 洗浄剤組成物
FR2653123B1 (fr) 1989-10-17 1992-01-17 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5066484A (en) 1990-04-30 1991-11-19 Revlon, Inc. Nail enamels containing glyceryl, glycol or citrate esters
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
FR2685638A1 (fr) 1991-12-31 1993-07-02 Biorga Sa Laboratoires Compositions pour l'usage cosmetique et/ou dermatologique, comprenant une association de pyrithione zinc, de piroctone olamine, et d'un derive de collagene et d'acide gras.
FR2685867B1 (fr) 1992-01-07 1995-06-09 Thorel Jean Compositions contre la desquamation de l'epiderme et du cuir chevelu.
DE4212105A1 (de) 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
FR2694694B1 (fr) 1992-08-13 1994-10-28 Thorel Jean Noel Composition active pour le traitement du psoriasis, notamment le psoriasis du cuir chevelu.
KR950702819A (ko) 1992-09-08 1995-08-23 제이코버스 코넬리스 레이서 실질적으로 무색의 순한 샴푸 조성물(mild, substantially coloriess shampoo compostion)
FR2697749B1 (fr) 1992-11-12 1995-01-13 Oreal Composition cosmétique filmogène à base d'un copolymère chloré greffé résultant du greffage d'une polyoléfine chlorée et de monomères insaturés du type acrylique, styrénique et/ou vinylique.
DE4333893A1 (de) 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
DE19518262A1 (de) 1995-05-18 1996-11-21 Hoechst Ag Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen
JP2945244B2 (ja) * 1993-05-24 1999-09-06 帝三製薬株式会社 酢酸ビニール系粘着剤を用いた硝酸イソソルビド含有貼付剤
FR2706299B1 (fr) * 1993-06-10 1995-09-01 Oreal Emulsion cosmétique ou dermatologique huile-dans-eau contenant une composition auto-émulsionnable à base d'un alcool gras et d'un alkylpolyoside et un co-émulsionnant.
ATE195431T1 (de) * 1993-09-01 2000-09-15 Teijin Ltd Emulsion auf der basis von 1-alpha,24-dihydroxy- vitamin d3
US5424435A (en) 1993-10-18 1995-06-13 Olin Corporation 1-hydroxy-6-substituted-2-pyridones
DE4336434A1 (de) 1993-10-26 1995-04-27 Hoechst Ag Pharmazeutische Zubereitung für die parenterale, enterale und dermale Verabreichung von praktisch unlöslichen Arzneistoffen und Verfahren zu ihrer Herstellung
US5480904A (en) 1993-10-28 1996-01-02 Eli Lilly And Company Methods for inhibiting uterine fibrosis
CA2177683C (en) * 1993-12-23 1999-12-28 George Endel Deckner Tissue moisturizing and antimicrobial compositions
JP3629283B2 (ja) * 1994-02-15 2005-03-16 ポーラ化成工業株式会社 皮膚外用剤
FR2718349B1 (fr) 1994-04-07 1996-05-31 Oreal Compositions cosmétiques à appliquer sur l'ongle.
JPH07325488A (ja) 1994-04-08 1995-12-12 Nippon Steel Corp 画像形成方法及び画像形成装置
FR2719481B1 (fr) * 1994-05-05 1996-05-31 Oreal Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.
FR2722689B1 (fr) 1994-07-20 1996-10-04 Fabre Pierre Dermo Cosmetique Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant
JPH08165244A (ja) * 1994-10-12 1996-06-25 Taisho Pharmaceut Co Ltd 皮膚疾患治療剤
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
US5696164A (en) 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
IL113057A (en) 1995-03-21 1999-01-26 Univ Ramot Compositions for the treatment of dandruff
US5609854A (en) * 1995-06-06 1997-03-11 Elizabeth Arden Company, Division Of Conopco, Inc. Thickened and stabilized cosmetic emulsion compositions
ATE217524T1 (de) 1995-12-04 2002-06-15 Aventis Pharma Gmbh Verwendung von 1-hydroxy-2-pyridonen zur behandlung von schwer therapierbaren schleimhauterkrankungen
DE19643831A1 (de) * 1996-10-30 1998-05-07 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von schwer therapierbaren Schleimhauterkrankungen
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
DE19639818A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung der Seborrhoischen Dermatitis
US20040039030A1 (en) * 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639817A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von Hautinfektionen
ES2198893T3 (es) 1998-02-09 2004-02-01 Macrochem Corporation Laca fungicida para uñas.
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel

Also Published As

Publication number Publication date
ATE216882T1 (de) 2002-05-15
US20060121118A1 (en) 2006-06-08
US20030190340A1 (en) 2003-10-09
ES2176702T3 (es) 2002-12-01
RS49596B (sr) 2007-06-04
US7018656B2 (en) 2006-03-28
OA11026A (fr) 2003-03-10
IL129140A0 (en) 2000-02-17
BG103262A (en) 1999-09-30
DE59707169D1 (de) 2002-06-06
US20040081677A1 (en) 2004-04-29
UA52699C2 (uk) 2003-01-15
KR100457850B1 (ko) 2004-11-18
AU4703797A (en) 1998-04-17
DE19639816A1 (de) 1998-04-02
KR20000048620A (ko) 2000-07-25
CN1149992C (zh) 2004-05-19
ID22149A (id) 1999-09-09
YU13599A (sh) 2002-03-18
PL188840B1 (pl) 2005-05-31
AU718837B2 (en) 2000-04-20
NO991458D0 (no) 1999-03-25
NZ334849A (en) 2000-09-29
EP0928192B1 (de) 2002-05-02
HUP9903804A3 (en) 2003-05-28
SI0928192T1 (en) 2002-08-31
BG63864B1 (bg) 2003-04-30
TR199900723T2 (xx) 1999-07-21
RU2181281C2 (ru) 2002-04-20
MY117863A (en) 2004-08-30
DK0928192T3 (da) 2002-08-19
BR9711559A (pt) 1999-08-24
ZA978638B (en) 1998-03-27
CN1231609A (zh) 1999-10-13
US7026337B2 (en) 2006-04-11
NO321899B1 (no) 2006-07-17
CY2371B1 (en) 2004-06-04
TW558442B (en) 2003-10-21
IL129140A (en) 2004-08-31
PL332604A1 (en) 1999-09-27
HK1022268A1 (en) 2000-08-04
CZ107399A3 (cs) 1999-07-14
PT928192E (pt) 2002-10-31
JP2001501609A (ja) 2001-02-06
WO1998013042A1 (de) 1998-04-02
EP0928192A1 (de) 1999-07-14
CA2267160A1 (en) 1998-04-02
MA24331A1 (fr) 1998-04-01
HUP9903804A1 (hu) 2000-03-28
NO991458L (no) 1999-03-25
HU228297B1 (en) 2013-03-28
CZ291170B6 (cs) 2003-01-15
CA2267160C (en) 2006-10-31

Similar Documents

Publication Publication Date Title
BR9709823B1 (pt) "compostos de amidas de ácido alqueno piridílico e alquino piridílico, métodos de preparação e uso dos mesmos, bem como medicamento".
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
AR025959A1 (es) DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
AR029174A1 (es) Derivados de espirooxindol, proceso para su preparacion, formulacion farmaceutica, y utilizacion de los derivados en la manufactura de medicamentos
FR2429593A1 (fr) Medicaments contenant des derives d'imidazole
MX9307940A (es) Nuevos derivados de la imidazopiridina, proceso para su preparacion y formulaciones farmaceuticas que los incluyen
YU69991A (sh) Derivati piridina
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
HU906284D0 (en) Process for the production of 24-homo-d-vitamin derivatives and medical preparations containing them as active agents
ES2184131T3 (es) Derivados de benzamidina y su utilizacion como medicamentos con efecto antagonista de ltb4.
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
FR2370733A1 (fr) Derives polysubstitues de la piperidine, leurs procedes de preparation et leur application en tant que medicaments
AR008858A1 (es) Preparados farmaceuticos que contienen derivados 1-hidroxi-2-(1h) piridona, procedimiento para su obtencion y empleo de los mismos para la preparacion deun medicamento para el tratamiento y profilaxis de micosis cutaneas.
ES2101858T3 (es) Derivados de geneserina como inhibidores de colinesterasa.
ES2128043T3 (es) Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral.
FR2521998B1 (fr) Pyrido (3,4-c) psoralenes, obtention, applications en cosmetologie et a titre de medicaments et compositions cosmetiques et pharmaceutiques les contenant
FR2387221A1 (fr) Derives du benzimidazole utilisables comme substances actives de medicaments veterinaires
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
FR2355502A1 (fr) Application a titre de medicaments d'un derive de la piperazine et de ses sels
AR023139A1 (es) Nuevos derivados de morfolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
FR2381781A1 (fr) Derives de la guanine et medicament contenant ces substances
CY1106819T1 (el) Φαρμακα για το ξηρο δερμα
NO147877C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-oksazepin-derivater
HUP9802005A2 (hu) Nátrium/hidrogén-csere inhibitorok alkalmazása különböző anyagok által a szívre gyakorolt nem kívánt hatások csökkentésére alkalmas gyógyszerkészítmények előállítására
FR2422647A1 (fr) Nouvelles 2,4-diamino-5-benzylpyrimidines, leur preparation et leur application en tant que medicaments

Legal Events

Date Code Title Description
FC Refusal